Aim: This study aims to assess the impacts of various trigger day progesterone (P4) and luteinizing hormone (LH) levels on live birth rates (LBRs) in fresh in vitro fertilization (IVF) cycles, considering their elevation from stimulation and premature luteinization.
Methods: This retrospective cohort study included the first ovarian stimulation cycles with GnRH antagonist protocol of 1253 patients who underwent intracytoplasmic sperm injection and fresh embryo transfer at a tertiary clinic's IVF center between 2010 and 2016. Participants were divided into four groups based on trigger day serum P4 and LH levels, using the 90th percentile thresholds for P4 (1.7 ng/mL) and LH (5.2 IU/L). The primary outcome measure was LBR.
Results: The LBRs observed in the respective groups were as follows: P4 < 1.7 ng/mL and LH <5.2 IU/L (21.3%, 214/1005); P4 < 1.7 ng/mL and LH ≥5.2 IU/L (19.1%, 22/115); P4 ≥ 1.7 ng/mL and LH <5.2 IU/L (19.3%, 23/119); and P4 ≥ 1.7 ng/mL and LH ≥5.2 IU/L (28.6%, 4/14). There were no statistically significant differences between the groups (p = 0.782). Additionally, a multivariate generalized additive model, adjusted for female age, body mass index, infertility duration, number of embryos transferred, and embryo transfer day, found that the interaction between LH and P4 levels did not significantly predict LBRs (p = 0.533). However, univariate analysis identified an optimal trigger day P4 range between 0.58 and 1.69 ng/mL for achieving higher LBRs, demonstrating a non-linear relationship. Furthermore, total FSH and LH dosages during stimulation had a statistically significant combined effect on trigger day P4 levels (p = <0.001), with the addition of LH leading to lower P4 levels compared to cycles stimulated with recombinant FSH alone.
Conclusions: The relationship and interaction between trigger day LH and P4 levels do not significantly influence LBRs, as variations in LH do not alter the effect of P4, suggesting that the impact of P4 elevation on LBRs is independent of its cause, whether from ovarian stimulation or premature luteinization.
Keywords: GnRH antagonist; ICSI; IVF; LH; Progesterone; live birth rate.
© 2025 Japan Society of Obstetrics and Gynecology.